Development and validation of an indigenous, radiobiological model-based tumor control probability and normal tissue complication probability estimation software for routine plan evaluation in clinics
- 1 January 2022
- journal article
- research article
- Published by Medknow in Journal of Cancer Research and Therapeutics
- Vol. 18 (6), 1697-1705
- https://doi.org/10.4103/jcrt.jcrt_330_20
Abstract
Purpose: Development and validation of a simple and convenient computational program in MATLAB environment for estimating the tumor control probability (TCP) and the normal tissue complication probability (NTCP), as a decision support system for routine plan evaluation. Materials and Methods: We developed an in-house software using MATLAB 2016b (Mathworks) for estimating TCP and NTCP named as RBMODELV1. The program contains Niemierko free equivalent uniform dose (EUD) program code provided in authors research article. For rest of radiobiological (RB) models in the software separate coding is performed. The program accepts cumulative dose–volume histogram file in (.txt) format containing two columns dose and volume. A set of two RB parameters were prepared, default and user-dependent in excel sheet named as RBDATA. We cross-validated results of RBMODELV1 software with BioSuite software for Poisson's TCP model and Lyman-Kutcher-Burman (LKB) model. A set of total 20 patient's data of head and neck site took under study and respective TCP and NTCP calculated by all the RB models and compared. Results: This is the first study in which we tried to establish correlation between the mean doses (EUD) received by parallel structure (parotid gland and oral cavity) and predicted percentage of NTCP values. It is found that mean dose in the range of 35–40 Gy for parotid gland can result in more than 50% NTCP predicted by all four RB models. Similarly oral cavity receiving mean dose in the range of 53–58 Gy can results in more than 35% NTCP predicted by all the four models. There is <3% variation observed between TCP calculated by BioSuite and RBMODELV1 software and <4% variation observed between predicted NTCP for parotid gland and oral cavity OAR from LKB model by both the software. Conclusion: We created simple software RBMODELV1 which can be used as a research tool as well as decision support system.Keywords
This publication has 25 references indexed in Scilit:
- Normal tissue complication probability model parameter estimation for xerostomia in head and neck cancer patients based on scintigraphy and quality of life assessmentsBMC Cancer, 2012
- Comparison of Dose Response Models for Predicting Normal Tissue Complications from Cancer Radiotherapy: Application in Rat Spinal CordCancers, 2011
- Dose volume histogram analysis and comparison of different radiobiological models using in-house developed softwareJournal of Medical Physics, 2011
- Mechanistic simulation of normal-tissue damage in radiotherapy-–implications for dose–volume analysesPhysics in Medicine & Biology, 2010
- A free software for the evaluation and comparison of dose response models in clinical radiotherapy (DORES)International Journal of Radiation Biology, 2009
- Lyman–Kutcher–Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical dataPhysics in Medicine & Biology, 2008
- A new formula for normal tissue complication probability (NTCP) as a function of equivalent uniform dose (EUD)Physics in Medicine & Biology, 2007
- Dose response explorer: an integrated open-source tool for exploring and modelling radiotherapy dose–volume outcome relationshipsPhysics in Medicine & Biology, 2006
- A TCP‐NTCP estimation module using DVHs and known radiobiological models and parameter setsJournal of Applied Clinical Medical Physics, 2004
- Reporting and analyzing dose distributions: A concept of equivalent uniform doseMedical Physics, 1997